Stemtech Corporation Empowers Growth With Debt-to-Equity Conversion, Strengthening Investor Confidence

Author's Avatar
Jun 13, 2023

Charles S. Arnold, Stemtech CEO, leads the charge as company reduces debt and expands equity position, signaling commitment to global stem cell nutrition market.